Mark Thaller

Dr. Mark Thaller

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2022 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
MTMark Thaller
Mark Thaller
VHVictoria Homer
Victoria Homer
YHYousef Hyder
Yousef Hyder
AYAndreas Yiangou
Andreas Yiangou
ALAnthony Liczkowski
Anthony Liczkowski
ASAlexandra Sinclair
Alexandra Sinclair
Background: There are limited longitudinal data evaluating outcomes in idiopathic intracranial hypertension (IIH). We aimed to evaluate the long-term outcomes in a real-world cohort of patients with IIH and sought to establish the prognostic factors. Methods: A longitudinal prospective cohort study was conducted over 9 years (2012–2021). Data included demographics and disease status. All consenting patients with IIH were recruited. Visual outcomes included visual acuity, Humphrey visual field and optical coherence tomography (OCT) imaging measurements. Headache frequency, severity, and impact were noted. We analysed the key variables impacting visual and headache outcomes. Results: The cohort contained 490 patients with a confirmed IIH diagnosis. 98% were female with a mean body mass index (BMI) of 38 kg/m2. Those with the highest OCT retinal nerve fibre layer had the worst visual outcomes. We noted a delayed decline, in the visual field and OCT ganglion cell layer after 12 months. In the medically managed cohort (n = 426), we found that disease duration and change in BMI had the greatest influence on visual outcomes. There was a high burden of headache, with a daily headache at presentation and prior migraine history influencing long-term headache prognosis. Conclusions: There is a delayed decline in visual outcomes in those with the most severe papilloedema. Disease duration and change in BMI were the key visual prognostic factors, therefore those with the more acute disease may require closer monitoring. Improving prognosis in IIH should focus on the potentially modifiable factor of weight management.

11 April 2023 in Neurology
Verified
Journal Article
Closed access
PDF file
MTMark Thaller
Mark Thaller
VHVictoria Homer
Victoria Homer
SMSusan P Mollan
Susan P Mollan
ASAlexandra Sinclair
Alexandra Sinclair
Background: Idiopathic intracranial hypertension (IIH) most typically occurs in women of childbearing age with increased weight as a key risk factor for development or exacerbation of the disease. Pregnancy is common in this group of patients. The longer-term impact of pregnancy on IIH has not been established and was the aim of this study. Methods: A prospective cohort study (IIH Life) recruited consecutive patients with IIH between 2012-2021 and evaluated outcomes including: vision (LogMAR visual acuity; Humphrey visual field perimetric mean deviation (PMD); optical coherence tomography (OCT) imaging) and headache. Four cohorts were evaluated: those with IIH diagnosed for the first time whilst pregnant; those with established IIH who became pregnant; those with a pregnancy prior to their diagnosis of IIH; and those with IIH who never became pregnant. Results: 377 people with IIH agreed to participate in the IIH Life maternal health study. Mean follow up was 17.5 months (standard deviation (SD) 20.5). IIH diagnosed in pregnancy was rare. Patients diagnosed with IIH whilst pregnant had greater papilloedema (mean OCT total retinal thickness +11.59 µm/month (95% CI: 1.25, 21.93)), although they had comparable visual field and acuity measures compared to those with established IIH who became pregnant during their disease course (-1.2 µm/month (95% CI: -2.6, 0.21)). In those with established IIH, pregnancy did not adversely affect visual or headache outcomes over time and the trajectory was akin to those with IIH that never had a pregnancy. Headache outcomes showed variability reflecting the IIH cohort as a whole. Discussion: A diagnosis of IIH whilst pregnant was rare but associated with more severe papilloedema. Long term visual outcomes in IIH were analogous irrespective of the timing of the pregnancy. This data is reassuring however close vigilance of IIH clinical features during pregnancy is recommended.

21 April 2022 in Practical Neurology
Verified
Journal Article
Open access
PDF file
MTMark Thaller
Mark Thaller
BWBenjamin R Wakerley
Benjamin R Wakerley
SASally Abbott
Sally Abbott
ATAbd Tahrani
Abd Tahrani
SMSusan P Mollan
Susan P Mollan
ASAlexandra Sinclair
Alexandra Sinclair
Idiopathic intracranial hypertension (IIH) is more common in women of reproductive age who have obesity, yet there is little information on its management specifically in pregnancy. Women with IIH should plan their pregnancy including discussing contraception before pregnancy, recognising that hormonal contraceptives are not contraindicated. Potentially teratogenic medications including acetazolamide and topiramate are not recommended during pregnancy or in those with immediate plans to conceive; prescribing acetazolamide in pregnancy must only follow discussion with the patient and their obstetrician. Ideally, patients should aim to achieve disease remission or control before pregnancy, through optimising their weight. Although weight gain is expected in pregnancy, excessive weight gain may exacerbate IIH and increase maternal and fetal complications; evidence-based recommendations for non-IIH pregnancies may help in guiding optimal gestational weight gain. The vast majority of women with IIH can have a normal vaginal delivery, with spinal or epidural anaesthesia if needed, provided the papilloedema is stable or the IIH is in remission.

21 June 2022 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
MTMark Thaller
Mark Thaller
JMJemma Mytton
Jemma Mytton
BWBenjamin R Wakerley
Benjamin R Wakerley
SMSusan P Mollan
Susan P Mollan
ASAlexandra Sinclair
Alexandra Sinclair
Objective: Idiopathic intracranial hypertension (IIH) predominantly affects women of reproductive age with obesity, and these women have a distinct profile of hyperandrogenism and insulin resistance. Polycystic ovary syndrome (PCOS) has an established adverse fertility phenotype that typically affects obese women. As IIH may impact reproductive health, we sought to evaluate fertility, gestational complications and pregnancy outcome in IIH.Design: Prospective cohort study from English Hospital Episode Statistics dataset.Setting: English hospitals, UK.Population: Women aged 18–45 years seen in English hospitals between 1 April 2002 and 31 March 2019. Patients were required to have an IIH diagnosis and were compared with those with PCOS and general population female controls.Main outcome measures: Pregnancies resulting in live births, complications of gestational diabetes and pre‐eclampsia, and method of delivery.Results: Data was collected from 17 587 IIH, 199633 PCOS and 10 947 012 women in the general population. The live birth rate, adjusted for age, was significantly lower among women with IIH (54.1%) than PCOS (67.9%), p < 0.0001 and the general population (57.7%), p < 0.0001. Pre‐eclampsia and gestational diabetes risks were higher following a diagnosis of IIH (5.3‐fold and 2.7‐fold, respectively, p < 0.0001) compared with the general population controls. Following a diagnosis of IIH, elective caesarean section rates were more than twice that of general population (odds ratio [OR] 2.4) and prior to a diagnosis of IIH (OR 2.2).Conclusions: These data indicate there are lower age‐adjusted total pregnancy rates, increased risk of pre‐eclampsia and gestational diabetes, and a doubling of elective caesarean section rates in those with a diagnosis of IIH.

24 December 2020 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
MTMark Thaller
Mark Thaller
GTGeorgios Tsermoulas
Georgios Tsermoulas
RSRosa Sun
Rosa Sun
SMSusan P Mollan
Susan P Mollan
ASAlexandra Sinclair
Alexandra Sinclair
The neurological complications of SARS-CoV-2 infection are increasingly being recognised, as is the impact of enforced lockdown on both acute admissions and those with pre-existing neurological conditions. Papilloedema is a medical emergency requiring correct identification, timely investigations and a multidisciplinary approach.1 During the first National lockdown, access to optometric and hospital services, in the UK, was limited to absolute emergencies. The aim of this study was to evaluate the impact of lockdown on those presenting with new onset papilloedema and those with existing idiopathic intracranial hypertension (IIH) at a neuroscience centre in the UK.

20 January 2023 in American Journal of Ophthalmology
Verified
Journal Article
Open access
YHYousef F. Hyder
Yousef F. Hyder
VHVictoria Homer
Victoria Homer
MTMark Thaller
Mark Thaller
MBMarian Byrne
Marian Byrne
GTGeorgios Tsermoulas
Georgios Tsermoulas
ASAlexandra Sinclair
Alexandra Sinclair
To characterize the phenotype of patients with idiopathic intracranial hypertension (IIH) who received cerebrospinal (CSF) diversion surgery and to detail the trajectory of recovery. Prospective cohort registry study. Patients with IIH with sight-threatening papilledema presenting to a single United Kingdom neuroscience center between 2019 and 2021 were included. Outcomes consisted of perimetric mean deviation (PMD) and optical coherence tomography measures of papilledema (retinal nerve fiber layer [RNFL]) and macular ganglion cell layer (GCL) in both eyes. Headache outcomes included monthly headache days (MHD). Logistic regression methods were used to model long-term outcomes. Fifty-one patients without previous surgical interventions were included (92% female, mean age 28.1 years [SD 8.4], body mass index 37.4 kg/m2 [SD 9.7], mean days of follow-up 330 [SD 209]). Measurements before surgery showed mean PMD -11.4 dB (SD 9.7), RNFL 364 µm (SD 128), Frisén grade papilledema 4.3 (SD 0.9). and MHD 23 (SD 10.6). At 1 month postoperatively, RNFL and PMD had improved by 38% and 4%, respectively. At 4 months postoperatively, papilledema had resolved. GCL declined by 13% over 12 months. MHD reduced by 75% 3 months postoperatively before returning to baseline levels by 12 months. Five patients (9.8%) required revision surgeries. Detailed characteristics of patients with sight-threatening IIH who received CSF diversion surgery and their typical postoperative recovery are presented. These parameters should guide physicians as to when patients with IIH may require surgery and enable the early identification of outliers who fail to respond. Papilledema and PMD recovered but GCL atrophy continued for 12 months. The implication of this delayed atrophy is unknown.